Top Markets
#1 Helium Helium +58.19%
#2 GEKKO GEKKO +48.56%
#3 Pons Pons +40.70%
#4 ADO Protocol ADO Protocol +39.08%
#5 Prom Prom +34.97%
#6 StonkBroker StonkBroker +32.30%
#7 TENDIES TENDIES +31.73%
#8 Collector Crypt Collector Crypt +26.66%
#9 Collect on Fanable Collect on Fanable +24.06%
#10 Cysic Cysic +22.93%
Coin of the day
Helium Helium
Beállítások
Nyelv
MAGYAR
Pénznem
USD
Téma
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

AMPH
Helyezés a részvények között #9658
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho... Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.
Részvényárfolyam
$22.00
Utolsó szinkronizálás: 2026-08-28
Piaci kapitalizáció
$970.00M
Változás (1 nap)
0.54%
Változás (1 év)
-28.16%
Ország
US
Kereskedés Amphastar Pharmaceuticals, Inc. (AMPH)

Kategória

Healthcare
Amphastar Pharmaceuticals, Inc. (AMPH) részvényárfolyamának története
Legmagasabb napi záróár: $21.12 ekkor: 2026-08-01

Legalacsonyabb napi záróár: $9.82 ekkor: 2014-06-01
Amphastar Pharmaceuticals, Inc. részvényárfolyamának története 2014 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) -11.84%
2025 -35.78%
2024 -30.46%
2023 106.09%
2022 32.04%
2021 15.64%
2020 -2.11%
2019 -6.67%
2018 8.09%
2017 -3.87%
2016 37.35%
2015 23.57%
2014 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 $171.67 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 $166.36 31.46%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 $37.84 25.87%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 $222.33 27.49%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $21.19 17.16%
IN